Quotient Bioresearch
Quotient Bioresearch is a leading provider of early-stage drug development sevices from discovery throuh to prrof-of-concept providing a unique portfolio of laboratory and clinical solutions.
Underpinned by a unique combination of medical and scientific capabilities, we continually strive to deliver the highest quality of service to our clients - in support of your endeavours to develop new and pioneering medicines and products. Our innovative range of services are provided on a standalone basis, or integrated, to deliver your bespoke development programmes.
From small molecules through to biopharmaceuticals and biomarkers, we are ready to answer your question
Contact details
Company details
Radiochemsitry: Quotient Amersham Radiochemcials Products and Services is a world leading provider of 14C and 3H radiolabelled compounds, GMP APIs and IMPs
Metabolism: Fully intergrated service for preclinical and clinical DMPL, Including key strengths in discovery PK and in vitro models
Bioanalytical Sciences: Quotient is a leader inthe bioanalysis of small molecules, biopharmaceuticals and biomarkers and provides a full global central lab service
Microbiology: Experts in the development of anti-microbials with core capabilties in global surveillance studies and molecular biology.
Early Clinical Development: Broad-based capabilites for phase I/IIa and specialists in Synthesis-to-clinic 14C-enabled development and translational Pharmaceutics drug product optimisation in man.
